EP3049088
PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.9.2014EP published:
17.2.2021EP application number:
14824091.4
EPO information:
European Patent Register
Max expiry date:
25.9.2034
Title:
PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING
Timeline
Today
26.9.2014EP application
17.2.2021EP Publication
Owner
Name:
Galderma S.A.Address:
World Trade Center Avenue Gratta-Paille 1,, 1000 Lausanne 30 Grey, CH
Inventor
Name:
SCHERER, Warren J.Address:
Lutz, FL 33558, US
Priority
Number:
201361960740 PDate:
26.9.2013Country:
US
Classification
Categories:
A61K 31/5575, A61K 45/06, A61P 17/02, A61P 43/00